Cassidy says White House dropped FDA nominee Heidi Overton rather than give abortion assurances
The Senate health committee’s Republican chair says anti-abortion senators sought commitments from the administration before it withdrew Overton’s nomination.

Review information is loading.
Republican senator Bill Cassidy said the White House withdrew Heidi Overton’s nomination to lead the US Food and Drug Administration rather than give anti-abortion senators the assurances they had sought from the administration.
Cassidy, who chairs the Senate health committee, offered his account after the White House pulled Overton’s nomination on Tuesday, 17 November. The committee had been scheduled to vote on her nomination the following morning.
In a post on X, Cassidy said he believed Overton would have had enough votes to pass both the committee and the full Senate. Anti-abortion senators had sought assurances on what he called “life issues”, he said, and “the Administration withdrew Dr. Overton rather than make such commitments”. CNN reported that the White House did not immediately comment on his account.
A senior administration official gave a different assessment of her prospects, telling Axios that Overton lacked the congressional support needed to move forward with confirmation. The Associated Press reported that, with 12 Republicans and 11 Democrats on the committee, she needed every Republican vote to advance.
Cassidy had himself been undecided. Two days before the withdrawal, he told CBS he still had questions and could not predict the committee vote. He had previously called Overton’s support for the administration’s plan to split combination vaccines, including the measles, mumps and rubella jab, “almost disqualifying”.
Overton also faced objections over abortion and e-cigarettes. CNN reported, citing two people familiar with the matter, that Republican senator Josh Hawley and anti-abortion groups had threatened to oppose her amid frustration over the administration’s approach to restricting the abortion pill mifepristone. Republican senators Susan Collins and Lisa Murkowski had concerns about Overton’s anti-abortion stance and her role in approving flavoured vapes, the network reported.
Overton, a physician and White House policy adviser, was nominated by President Donald Trump in August. Kyle Diamantas has led the FDA as acting commissioner since May; CNN reported that the White House had not given a timetable for choosing another nominee.
Sign in to give this article a thumbs up or down.
From the discussion
Private test discussion. Comments are readers’ views and are not yet automatically fact-checked. Editing is available for 60 seconds after posting.
Sign in with a confirmed reader account and choose a username to read comments and participate.
Sorting applies to top-level comments; replies remain oldest first. New comments and likes can change the order. Refresh for the current ranking.
Loading comments…